In vitro drug sensitivity testing of bone sarcoma patients
Objectives and questions: Bone-derived sarcomas (BS) are a heterogeneous group of rare malignant tumors that occur throughout the entire skeleton. Current treatment strategies include a variable combination of surgical en bloc resection, (neo)adjuvant chemotherapy (CTx) before and after surgery and [for full text, please go to the a.m. URL]
Institutions
- National Center for Tumor Diseases (DE)
- Klinik und Poliklinik für Psychotherapie und Psychosomatik (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2025-10-31
- DOI
- https://doi.org/10.3205/25dkou388
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00